TNF and inflammatory bowel disease: The introduction of biological agents with strong anti-inflammatory action, such as anti-tumor necrosis factor (TNF) agents, have greatly contributed to changes in IBD treatment strategy and goals, which is advantageous for the long-term prognosis of patients (13–15).